Adamas Pharmaceuticals reported 239.75M in Market Capitalization for its second fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Market Capitalization Change
Abbvie ABBV:US $ 198.95B 7.96B
Acadia Pharmaceuticals ACAD:US $ 3.91B 222.46M
Acorda Therapeutics ACOR:US $ 45.26M 955.08K
Adamas Pharmaceuticals ADMS:US 239.75M 41.19M
Aerie Pharmaceuticals AERI:US $ 750.76M 87.28M
Aptinyx Inc APTX:US $ 192.93M 7.74M
Biocryst Pharmaceuticals BCRX:US $ 2.81B 1B
Flexion Therapeutics FLXN:US $ 411.02M 35.8M
GlaxoSmithKline GSK:LN 71.42B 6.62B
Glaxosmithkline GSK:US 98.75B 9.46B
Gw Pharmaceuticals GWPH:US 6.44B 2.84B
Heron Therapeutics HRTX:US $ 1.58B 98.85M
Intra Cellular Therapies ITCI:US $ 3.32B 573.64M
Marinus Pharmaceuticals MRNS:US $ 657.2M 90.12M
Merk MRK:US $ 196918.18M 1780.24M
Neurocrine Biosciences NBIX:US $ 9.2B 7.62M
Novartis NOVN:VX 208.02B 8.76B
Omeros OMER:US $ 924.95M 177.47M
Prothena PRTA:US 2.27B 1.17B
Revance Therapeutics RVNC:US $ 2.13B 132.96M
Teva Pharmaceutical TEVA:IT 35.79B 6.09B
UCB UCB:BB 17.15B 715.78M
Zogenix ZGNX:US $ 964.44M 125.02M